Albemarle (ALB) Rises As Market Takes a Dip: Key Facts

Albemarle (ALB) ended the recent trading session at $77.07, demonstrating a +1.76% change from the preceding day's closing price. The stock outpaced the S&P 500's daily loss of 0.01%. Elsewhere, the Dow lost 0.32%, while the tech-heavy Nasdaq added 0.05%. Shares of the specialty chemicals company have appreciated by 27.51% over the course of the past month, outperforming the Basic Materials sector's gain of 1.67%, and the S&P 500's gain of 5.37%.The investment community will be closely monitoring the performance of Albemarle in its forthcoming earnings report. The company is scheduled to release its earnings on July 30, 2025. On that day, Albemarle is projected to report earnings of -$0.83 per share, which would represent a year-over-year decline of 2175%. Meanwhile, our latest consensus estimate is calling for revenue of $1.23 billion, down 13.67% from the prior-year quarter. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$2.02 per share and revenue of $4.86 billion. These totals would mark changes of +13.68% and -9.54%, respectively, from last year. Any recent changes to analyst estimates for Albemarle should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability. Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 24.78% lower. Albemarle is currently a Zacks Rank #4 (Sell). The Chemical - Diversified industry is part of the Basic Materials sector. This industry, currently bearing a Zacks Industry Rank of 228, finds itself in the bottom 8% echelons of all 250+ industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions. Should You Invest in Albemarle Corporation (ALB)?Before you invest in Albemarle Corporation (ALB), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.Zacks Investment Research has been committed to providing investors with tools and independent research since 1978. For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover a period from January 1, 1988 through May 6, 2024.)Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Albemarle Corporation (ALB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks